Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Debt/Equity

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Total Debt/Equity(x) 0.250.130.460.400.67

What is the latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS is 0.25 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.25
Mar20240.13
Mar20230.46
Mar20220.40
Mar20210.67

How is Total Debt/Equity of GLENMARK PHARMACEUTICALS Trending?

Years Total Debt/Equity % Change
Mar2025 0.25
92.31
Mar2024 0.13
-71.74
Mar2023 0.46
15.00
Mar2022 0.4
-40.30
Mar2021 0.67 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Total Debt/Equity ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,925.2 Cr 4.9% 6% 63.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,531.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹169,989.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,936.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹109,200.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,057.0 Cr -1.5% 5.7% 14.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.9%

6%

63.6%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses